Replay
Featured Products
Building the Future
Leadership Perspective
Watch a video featuring our IP & Science business president Chris Kibarian
-
BUILDING
Our tools help researchers at The Michael J. Fox Foundation work towards a cure for Parkinson’s disease.
-
BUILDING
We reinforce the strong global legal foundation that is facilitating continuing growth for Nike, Inc.
-
BUILDING
At Lloyds Banking Group, our regulatory intelligence provides essential guidance to the bank’s compliance and risk group.
-
BUILDING
We make it easier for AGCO South America to navigate one of the world’s most complex tax environments.
-
BUILDING
In an industry where trust is everything, we’re part of investment firm Maxim Group’s toolkit for building informed advice.
Building
Established by the actor Michael J. Fox in 2000, the Foundation is dedicated to finding a cure for Parkinson’s disease through aggressively funded research, and to ensuring the development of better therapies for those living with the disease.
The Michael J. Fox Foundation forParkinson’s Research
At The Michael J. Fox Foundation in New York, Brian Fiske heads a research team working to uncover new insights into Parkinson’s disease. The degenerative neurological disorder strikes one in every 100 people over the age of 60. As Parkinson’s has no clear biomarker, geneticists and neuroscientists like Fiske rely on collaborative tools and shared data to further their understanding of the disease. The MetaCore™ database is foundational to exploration of LRRK2—a promising effort in their search for a cure. Fiske and his colleagues are building hope for a future free from Parkinson’s.
#1
Most
PrevalentResearchers estimate that Parkinson’s afflicts more than six million people worldwide—making it the #1 most prevalent movement disorder disease, more than multiple sclerosis, muscular dystrophy and Lou Gehrig’s disease combined.
200K+
Pathways
CapturedMetaCore’s more than 2,000 interactive maps with consensus knowledge of human biology and diseases capture nearly 200,000 pathways.
10
Million
ResearchersOur IP & Science products and services are used by up to 10 million scientific researchers around the world.
Parkinson’s disease researchers study the brain as part of their work to develop new treatments for Parkinson’s, including cell replacement therapy.
A researcher at the City College of New York fills test tubes in the College’s lab. She is among the recipients of the more than $275 million in Parkinson’s research funding that the Foundation has awarded to date.
Brian Fiske, who earned his doctoral degree in neuroscience, leads the research programs team at the Foundation. The team works to identify and pursue the most promising approaches to treating Parkinson’s disease.
